Korean

National Institute of Health Korea Vaccine Resarch Center

Mobile Menu

Pandemic Preparedness Strategies

Overseas cooperation Institutions

Background
  • There is a need to establish an international cooperation system, such as joint research and establishing domestic and international networks, etc.

    - Prioritizing the establishment of a cooperation system with CEPI (100 days mission), which has announced rapid vaccine development in preparation for public health emergencies

Status of the cooperation institution (CEPI)
1

(About CEPI) Its purpose is to secure necessary global health by accelerating the development of vaccines against infectious diseases and pandemic threats.

＊ It was established with support from the Bill & Melinda Gates Foundation, Wellcome Trust, World Economic Forum, etc.

< Main activities >

  • (The first three-year term after its establishment) It has focused on the development of vaccines against high-risk pathogens* for low- and middle-income countries
  • (2017-2021). The first five-year term after its establishment were named CEPI 1.0.

    - (CEPI 1.0 Strategy) was to invest, coordinate and accelerate vaccine progression through clinical development towards delivery, making them accessible to all people in need.

  • (CEPI 2.0 Strategy) aims to develop safe and effective vaccine in 100 days from the moment the a pathogen is sequenced and/or the need for a vaccine is recognized to initial.
Background
  • IVI : The first international organization headquartered in Korea hosted by the Korean government (June 1994)

  • * It hosting conditions: research institute building (16,982㎡), research equipment (about $6 million) and 30% support for operating expenses, granting privileges and tax exemptions equivalent to international organizations for the institute and foreign employees

About IVI
  • The world’s only non-profit international organization that conducts international vaccine research and development

    - It is involved in the discovery, development and distribution of safe, effective and inexpensive vaccines to improve health conditions and prevent infectious diseases in low- and middle-income countries.

  • (Main Activities) Vaccine development and distribution for low- and middle-income countries and global public health

    - Providing services (vaccine research and development, technology transfer, and training) to eradicate infectious diseases* in low- and middle-income countries.

    * Cholera, typhoid fever, iNTS, paratyphoid fever, dysentery, Zika, Adenovirus

    - Promoting vaccine-related R&D in cooperation with related organizations such as vaccine manufacturers, foundations, and governments